ARDX
ARDELYX, INC.
NASDAQ · Healthcare · Biotechnology · US
$3.42
+1.18%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 12.86x
- P/E 2028E
- 4.11x
- P/S forward
- 1.67x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.93x
- Price / sales
- 1.96x
- Price / cash flow
- -50.98x
Enterprise value
- Enterprise value
- $857.4M
- EV / sales
- 1.90x
- EV / EBITDA
- -36.05x
- EV / EBIT
- -24.18x
- Market cap
- $883.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026